[1]
M. Alavi-Moghaddam, S.-M. Alavian, and B. Hajibeigi, “Preliminary report on safety and response rate of pegylated interferon- alpha 2a (pegasys) in genotype D chronic hepatitis B patients in Iran”, Gastroenterol Hepatol Bed Bench, vol. 3, no. 2, Mar. 2010.